{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:50:31Z","timestamp":1774432231799,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Ministry for Education and Research","award":["BMBF KS2018-073"],"award-info":[{"award-number":["BMBF KS2018-073"]}]},{"name":"Universit\u00e4tsklinikum Leipzig"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) have a major negative impact on health status, rates of hospitalization, readmission, disease progression and mortality. Non-invasive ventilation (NIV) is the standard therapy for hypercapnic acidotic respiratory failure in AECOPD. Despite its beneficial effects, NIV is often poorly tolerated (11\u201334 % failure rate). An increasing number of studies have documented a beneficial effect of nasal high-flow (NHF) in acute hypercapnia. We designed a prospective, randomized, multi-centre, open label, non-inferiority trial to compare treatment failure in nasal NHF vs NIV in patients with acidotic hypercapnic AECOPD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study will be conducted in about 35 sites in Germany. Patients with hypercapnic AECOPD with respiratory acidosis (pH &lt;\u20097.35) will be randomized 1:1 to NIV or NHF. The primary outcome is the combined endpoint of intubation, treatment failure or death at 72\u2009h. The switch from one to the other device marks a device failure but acts as a rescue treatment in absence of intubation criteria. A sample size of 720 was calculated to have 80% power for showing that NHF is non-inferior to NIV with a margin of 8 percentage points. Linear regression will be used for the confirmatory analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>If NHF is shown to be non-inferior to NIV in acidotic hypercapnic AECOPD, it could become an important alternative treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04881409?term=wirtz&amp;draw=2&amp;rank=1\">NCT04881409<\/jats:ext-link>, Registered on May 11, 2021<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-021-05978-z","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T13:03:58Z","timestamp":1641819838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Nasal high-flow compared to non-invasive ventilation in treatment of acute acidotic hypercapnic exacerbation of chronic obstructive pulmonary disease\u2014protocol for a randomized controlled noninferiority trial (ELVIS)"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6147-6366","authenticated-orcid":false,"given":"Jens","family":"Br\u00e4unlich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"K\u00f6ppe-Bauernfeind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Petroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annegret","family":"Franke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"5978_CR1","unstructured":"Decker R. 2020 GOLD REPORT. https:\/\/goldcopd.org\/wp-content\/uploads\/2019\/11\/GOLD-2020-REPORT-ver1.1wms.pdf. Published online December 12, 2019:1-141."},{"key":"5978_CR2","doi-asserted-by":"publisher","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Samet J, ed. PLoS medicine. 2006;3(11):e442. doi:https:\/\/doi.org\/10.1371\/journal.pmed.0030442","DOI":"10.1371\/journal.pmed.0030442"},{"issue":"9","key":"5978_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/s2213-2600(17)30293-x","volume":"5","author":"JB Soriano","year":"2017","unstructured":"Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, et al. Articles Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691\u2013706. https:\/\/doi.org\/10.1016\/s2213-2600(17)30293-x.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"5978_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1183\/13993003.01391-2014","volume":"47","author":"S Hartl","year":"2016","unstructured":"Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J. 2016;47(1):113\u201321. https:\/\/doi.org\/10.1183\/13993003.01391-2014.","journal-title":"Eur Respir J"},{"issue":"7","key":"5978_CR5","doi-asserted-by":"publisher","first-page":"CD004104","DOI":"10.1002\/14651858.cd004104.pub4","volume":"7","author":"CR Osadnik","year":"2017","unstructured":"Osadnik CR, Tee VS, Carson-Chahhoud KV, Picot J, Wedzicha JA, Smith BJ. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;7(7):CD004104. https:\/\/doi.org\/10.1002\/14651858.cd004104.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"5978_CR6","doi-asserted-by":"publisher","unstructured":"Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, Navalesi (members o P, Antonelli M, Brozek J, Conti G, Ferrer M, Guntupalli K, Jaber S, Keenan S, Mancebo J, Mehta S, Raoof (members o S Official ERS\/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50(2):1602426. doi:https:\/\/doi.org\/10.1183\/13993003.02426-2016","DOI":"10.1183\/13993003.02426-2016"},{"issue":"9","key":"5978_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/thorax.56.9.708","volume":"56","author":"PK Plant","year":"2001","unstructured":"Plant PK, Owen JL, Elliott MW. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome. Thorax. 2001;56(9):708\u201312. https:\/\/doi.org\/10.1136\/thorax.56.9.708.","journal-title":"Thorax"},{"issue":"3","key":"5978_CR8","doi-asserted-by":"publisher","first-page":"473.e7","DOI":"10.1016\/j.jcrc.2008.08.007","volume":"24","author":"M Carrera","year":"2009","unstructured":"Carrera M, Marin JM, Ant\u00f3n A, et al. A controlled trial of noninvasive ventilation for chronic obstructive pulmonary disease exacerbations. J Crit Care. 2009;24(3):473.e7\u201314. https:\/\/doi.org\/10.1016\/j.jcrc.2008.08.007.","journal-title":"J Crit Care"},{"issue":"2","key":"5978_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1183\/09031936.05.00085304","volume":"25","author":"M Confalonieri","year":"2005","unstructured":"Confalonieri M, Garuti G, Cattaruzza MS, Osborn JF, Antonelli M, Conti G, et al. Italian noninvasive positive pressure ventilation (NPPV) study group. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J. 2005;25(2):348\u201355. https:\/\/doi.org\/10.1183\/09031936.05.00085304.","journal-title":"Eur Respir J"},{"key":"5978_CR10","doi-asserted-by":"publisher","unstructured":"Tissot A, Jaffre S, Gagnadoux F, et al. Home non-invasive ventilation fails to improve quality of life in the elderly: results from a multicenter cohort study. Staffieri F, ed. PloS one. 2015;10(10):e0141156. doi:https:\/\/doi.org\/10.1371\/journal.pone.0141156","DOI":"10.1371\/journal.pone.0141156"},{"issue":"1","key":"5978_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12890-018-0576-x","volume":"18","author":"J Br\u00e4unlich","year":"2018","unstructured":"Br\u00e4unlich J, Mauersberger F, Wirtz H. Effectiveness of nasal highflow in hypercapnic COPD patients is flow and leakage dependent. BMC Pulm Med. 2018;18(1):14. https:\/\/doi.org\/10.1186\/s12890-018-0576-x.","journal-title":"BMC Pulm Med"},{"issue":"4","key":"5978_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000342027","volume":"85","author":"J Br\u00e4unlich","year":"2013","unstructured":"Br\u00e4unlich J, Beyer D, Mai D, Hammerschmidt S, Seyfarth HJ, Wirtz H. Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration. 2013;85(4):319\u201325. https:\/\/doi.org\/10.1159\/000342027.","journal-title":"Respiration"},{"key":"5978_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.resp.2017.03.012","volume":"242","author":"J Br\u00e4unlich","year":"2017","unstructured":"Br\u00e4unlich J, Goldner F, Wirtz H. Nasal highflow eliminates CO2 from lower airways. Respir Physiol Neurobiol. 2017;242:86\u20138. https:\/\/doi.org\/10.1016\/j.resp.2017.03.012.","journal-title":"Respir Physiol Neurobiol"},{"key":"5978_CR14","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2147\/copd.s206111","volume":"14","author":"J Br\u00e4unlich","year":"2019","unstructured":"Br\u00e4unlich J, Dellweg D, Bastian A, Budweiser S, Randerath W, Trich\u00e9 D, et al. Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD. Int J Chronic Obstruct Pulmonary Dis. 2019;14:1411\u201321. https:\/\/doi.org\/10.2147\/copd.s206111.","journal-title":"Int J Chronic Obstruct Pulmonary Dis"},{"key":"5978_CR15","doi-asserted-by":"publisher","unstructured":"Biselli P, Fricke K, Grote L, et al. Reductions in dead space ventilation with nasal high flow depend on physiological dead space volume: metabolic hood measurements during sleep in patients with COPD and controls. Eur Respir J. 2018;51(5). https:\/\/doi.org\/10.1183\/13993003.02251-2017.","DOI":"10.1183\/13993003.02251-2017"},{"issue":"23","key":"5978_CR16","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/nejmoa1503326","volume":"372","author":"JP Frat","year":"2015","unstructured":"Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. New Engl J Medicine. 2015;372(23):2185\u201396. https:\/\/doi.org\/10.1056\/nejmoa1503326.","journal-title":"New Engl J Medicine"},{"issue":"3","key":"5978_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1164\/rccm.201402-0364oc","volume":"190","author":"SM Maggiore","year":"2014","unstructured":"Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, et al. Nasal high-flow versus venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med. 2014;190(3):282\u20138. https:\/\/doi.org\/10.1164\/rccm.201402-0364oc.","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"5978_CR18","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2016.14194","volume":"316","author":"G Hern\u00e1ndez","year":"2016","unstructured":"Hern\u00e1ndez G, Vaquero C, Colinas L, Cuena R, Gonz\u00e1lez P, Canabal A, et al. Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients: a randomized clinical trial. JAMA. 2016;316(15):1565\u201374. https:\/\/doi.org\/10.1001\/jama.2016.14194.","journal-title":"JAMA"},{"key":"5978_CR19","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.2147\/copd.s185001","volume":"13","author":"J Br\u00e4unlich","year":"2018","unstructured":"Br\u00e4unlich J, Wirtz H. Nasal high-flow in acute hypercapnic exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3895\u20137. https:\/\/doi.org\/10.2147\/copd.s185001.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5978_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2147\/copd.s104616","volume":"11","author":"J Br\u00e4unlich","year":"2016","unstructured":"Br\u00e4unlich J, K\u00f6hler M, Wirtz H. Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1077\u201385. https:\/\/doi.org\/10.2147\/copd.s104616.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"5978_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ppul.21326","volume":"46","author":"M Frizzola","year":"2011","unstructured":"Frizzola M, Miller TL, Rodriguez ME, Zhu Y, Rojas J, Hesek A, et al. High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung injury model. Pediatr Pulmonol. 2011;46(1):67\u201374. https:\/\/doi.org\/10.1002\/ppul.21326.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"5978_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/thoraxjnl-2016-209673","volume":"72","author":"L Pisani","year":"2017","unstructured":"Pisani L, Fasano L, Corcione N, Comellini V, Musti MA, Brandao M, et al. Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax. 2017;72(4):373\u20135. https:\/\/doi.org\/10.1136\/thoraxjnl-2016-209673.","journal-title":"Thorax"},{"issue":"10","key":"5978_CR23","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ajem.2015.07.060","volume":"33","author":"JH Jeong","year":"2015","unstructured":"Jeong JH, Kim DH, Kim SC, Kang C, Lee SH, Kang TS, et al. Changes in arterial blood gases after use of high-flow nasal cannula therapy in the ED. Am J Emerg Med. 2015;33(10):1344\u20139. https:\/\/doi.org\/10.1016\/j.ajem.2015.07.060.","journal-title":"Am J Emerg Med"},{"key":"5978_CR24","doi-asserted-by":"publisher","unstructured":"Doshi P, Whittle JS, Bublewicz M, et al. High-velocity nasal insufflation in the treatment of respiratory failure: a randomized clinical trial. Ann Emerg Med. Published online January 5, 2018;72(1):73-83. doi:https:\/\/doi.org\/10.1016\/j.annemergmed.2017.12.006","DOI":"10.1016\/j.annemergmed.2017.12.006"},{"key":"5978_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.rmed.2016.11.004","volume":"121","author":"CC Lee","year":"2016","unstructured":"Lee CC, Mankodi D, Shaharyar S, Ravindranathan S, Danckers M, Herscovici P, et al. High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: a systematic review. Respiratory Med. 2016;121:100\u20138. https:\/\/doi.org\/10.1016\/j.rmed.2016.11.004.","journal-title":"Respiratory Med"},{"key":"5978_CR26","doi-asserted-by":"publisher","unstructured":"Pisani L, Betti S, Biglia C, et al. Effects of high-flow nasal cannula in patients with persistent hypercapnia after an acute COPD exacerbation: a prospective pilot study. BMC Pulm Med. 2020;20(1):12. Published online January 11, 2020:1-9. doi:https:\/\/doi.org\/10.1186\/s12890-020-1048-7","DOI":"10.1186\/s12890-020-1048-7"},{"issue":"8","key":"5978_CR27","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0895-4356(03)00088-X","volume":"56","author":"W Windisch","year":"2003","unstructured":"Windisch W, Freidel K, Schucher B, Baumann H, Wiebel M, Matthys H, et al. The Severe Respiratory Insufficiency (SRI) Questionnaire: a specific measure of health-related quality of life in patients receiving home mechanical ventilation. J Clin Epidemiol. 2003;56(8):752\u20139. https:\/\/doi.org\/10.1016\/S0895-4356(03)00088-X.","journal-title":"J Clin Epidemiol"},{"key":"5978_CR28","doi-asserted-by":"crossref","unstructured":"Jones PW, Quirk FH, Baveystock CM. The St George\u2019s Respiratory Questionnaire. Respiratory Med. 1991;85 Suppl B:25-31-discussion 33-7.","DOI":"10.1016\/S0954-6111(06)80166-6"},{"issue":"6","key":"5978_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","volume":"145","author":"PW Jones","year":"1992","unstructured":"Jones PW. A self-complete measure of health status for chronic airflow limitation. The St. George\u2019s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321\u20137. https:\/\/doi.org\/10.1164\/ajrccm\/145.6.1321.","journal-title":"Am Rev Respir Dis"},{"key":"5978_CR30","unstructured":"Committee for Medicinal Products for Human Use (CHMP): Guideline on the choice of the non-inferiority margin. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-choice-non-inferiority-margin_en.pdf) Published online May 30, 2006."},{"key":"5978_CR31","volume-title":"Kaysville","author":"JPASS Hintze","year":"2011","unstructured":"Hintze JPASS. Kaysville. Utah, USA: NCSS; 2011. (Software)"},{"issue":"12","key":"5978_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00134-020-06312-y","volume":"46","author":"B Rochwerg","year":"2020","unstructured":"Rochwerg B, Einav S, Chaudhuri D, Mancebo J, Mauri T, Helviz Y, et al. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med. 2020;46(12):1\u201312. https:\/\/doi.org\/10.1007\/s00134-020-06312-y.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5978_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2020.9524","volume":"324","author":"BL Ferreyro","year":"2020","unstructured":"Ferreyro BL, Angriman F, Munshi L, del Sorbo L, Ferguson ND, Rochwerg B, et al. Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure. JAMA. 2020;324(1):57\u201311. https:\/\/doi.org\/10.1001\/jama.2020.9524.","journal-title":"JAMA"},{"issue":"1","key":"5978_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40248-015-0019-y","volume":"10","author":"J Br\u00e4unlich","year":"2015","unstructured":"Br\u00e4unlich J, Seyfarth HJ, Wirtz H. Nasal high-flow versus non-invasive ventilation in stable hypercapnic COPD: a preliminary report. Multidiscip Respir Med. 2015;10(1):27. https:\/\/doi.org\/10.1186\/s40248-015-0019-y.","journal-title":"Multidiscip Respir Med"},{"issue":"1","key":"5978_CR35","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1186\/s13054-020-03409-0","volume":"24","author":"A Cortegiani","year":"2020","unstructured":"Cortegiani A, Longhini F, Madotto F, et al. High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial. Crit Care. 2020;24(1):692. https:\/\/doi.org\/10.1186\/s13054-020-03409-0.","journal-title":"Crit Care"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05978-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05978-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05978-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T13:23:15Z","timestamp":1641820995000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05978-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5978"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05978-z","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"19 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial protocol has been approved by the Ethics Committee of the University of Leipzig (595\/20-ek) and first patient-in is anticipated in May 2021. Consent to participate in the trials will be obtained from every patient according to national guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JB received speaker fees from Fisher&Paykel Healthcare, grants, equipment and speaker fees from TNI medical AG, speaker fees from Masimo.HW received grants, equipment and speaker fees from TNI medical AG.No other authors report conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}